CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Valtis YK, Lin C, Nemirovsky D, Devlin S, Rejeski K, Curran KJ, Wang X, Shah NN, Jeyakumar N, Miller K, Zhang A, Kota VK, Al Darobi AH, Muhsen I, Sasine J, Aldoss I, Advani AS, Reshef R, Chen EC, Kopmar N, Tsai SB, Hilal T, Shah BD, Faramand R, Solh MM, Tan V, Bezerra E, Battiwalla M, Ramakrishnan A, Mathews J, Shaughnessy P, Mountjoy L, Hoeg RT, Dykes KC, Logan AC, Kumaran MV, Schwartz M, Tracy S, Moore J, Odstrcil Bobillo S, Frey NV, Connor M, Ladha A, Dholaria B, Sutherland K, Roloff GW, Muffly LS, Park JH

Open source

DOI
10.1182/bloodadvances.2025017526
Published
2026 Jan 13
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025017526,
  title = {CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.},
  author = {Valtis YK and Lin C and Nemirovsky D and Devlin S and Rejeski K and Curran KJ and Wang X and Shah NN and Jeyakumar N and Miller K and Zhang A and Kota VK and Al Darobi AH and Muhsen I and Sasine J and Aldoss I and Advani AS and Reshef R and Chen EC and Kopmar N and Tsai SB and Hilal T and Shah BD and Faramand R and Solh MM and Tan V and Bezerra E and Battiwalla M and Ramakrishnan A and Mathews J and Shaughnessy P and Mountjoy L and Hoeg RT and Dykes KC and Logan AC and Kumaran MV and Schwartz M and Tracy S and Moore J and Odstrcil Bobillo S and Frey NV and Connor M and Ladha A and Dholaria B and Sutherland K and Roloff GW and Muffly LS and Park JH},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2025017526},
  url = {https://doi.org/10.1182/bloodadvances.2025017526}
}

RIS

TY  - JOUR
TI  - CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.
AU  - Valtis YK
AU  - Lin C
AU  - Nemirovsky D
AU  - Devlin S
AU  - Rejeski K
AU  - Curran KJ
AU  - Wang X
AU  - Shah NN
AU  - Jeyakumar N
AU  - Miller K
AU  - Zhang A
AU  - Kota VK
AU  - Al Darobi AH
AU  - Muhsen I
AU  - Sasine J
AU  - Aldoss I
AU  - Advani AS
AU  - Reshef R
AU  - Chen EC
AU  - Kopmar N
AU  - Tsai SB
AU  - Hilal T
AU  - Shah BD
AU  - Faramand R
AU  - Solh MM
AU  - Tan V
AU  - Bezerra E
AU  - Battiwalla M
AU  - Ramakrishnan A
AU  - Mathews J
AU  - Shaughnessy P
AU  - Mountjoy L
AU  - Hoeg RT
AU  - Dykes KC
AU  - Logan AC
AU  - Kumaran MV
AU  - Schwartz M
AU  - Tracy S
AU  - Moore J
AU  - Odstrcil Bobillo S
AU  - Frey NV
AU  - Connor M
AU  - Ladha A
AU  - Dholaria B
AU  - Sutherland K
AU  - Roloff GW
AU  - Muffly LS
AU  - Park JH
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2025017526
UR  - https://doi.org/10.1182/bloodadvances.2025017526
ER  -

APA

YK, V., C, L., D, N., S, D., K, R., KJ, C., X, W., NN, S., N, J., K, M., A, Z., VK, K., AH, A. D., I, M., J, S., I, A., AS, A., R, R., EC, C., N, K., SB, T., T, H., BD, S., R, F., MM, S., V, T., E, B., M, B., A, R., J, M., P, S., L, M., RT, H., KC, D., AC, L., MV, K., M, S., S, T., J, M., S, O. B., NV, F., M, C., A, L., B, D., K, S., GW, R., LS, M., & JH, P. (2026). CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.. Blood advances. https://doi.org/10.1182/bloodadvances.2025017526

Source records